[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Acinetobacter Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 150 pages | ID: AC7D1417F874EN
VPAResearch

US$ 1,699.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Acinetobacter Infections Drug pipeline report- 2020 is an annual R&D review of Acinetobacter Infections pipeline candidates. The report presents the current status of all major Acinetobacter Infections therapeutic compounds. Detailed insights into Acinetobacter Infections pipeline development, current status, companies, drug profiles and Acinetobacter Infections preclinical and clinical trials are included.

2020 Acinetobacter Infections Pipeline Market Insights
Acinetobacter Infections disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Acinetobacter Infections therapies, pipeline by phase and others are included.

Acinetobacter Infections pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Acinetobacter Infections Therapeutic Drug candidates
Both active and inactive Acinetobacter Infections pipeline drug candidates are included in the report

Acinetobacter Infections Clinical Trials and preclinical Studies
Acinetobacter Infections In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Acinetobacter Infections pipeline market developments
Acinetobacter Infections Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Acinetobacter Infections pipeline companies in active development
The report analyzes Acinetobacter Infections pipeline of the below companies-

ABAC Therapeutics SA, Abgentis Ltd, Achaogen Inc, Acies Bio, d.o.o., AiCuris GmbH & Co KG, AmpliPhi Biosciences Corp, Appili Therapeutics Inc, Aridis Pharmaceuticals Inc, AstraZeneca Plc, Atterx Biotherapeutics Inc, Bioharmony Therapeutics Inc, C3J Therapeutics Inc, Chelation Partners Inc, ContraFect Corporation, CSA Biotechnologies LLC, Destiny Pharma Plc, Eligochem Ltd, EnBiotix Inc, Entasis Therapeutics Inc, F. Hoffmann-La Roche Ltd, Fedora Pharmaceuticals Inc, Forge Therapeutics Inc, Fundaci?n MEDINA, Hsiri Therapeutics LLC, KBP BioSciences Co Ltd, LegoChem Biosciences Inc, Meiji Seika Pharma Co Ltd, Melinta Therapeutics Inc, Neoculi Pty Ltd, Novabiotics Ltd, Octagon Therapeutics Inc, Peptilogics Inc, Pfizer Inc, Pylum Biosciences Inc, Redx Pharma Plc, RMH Sciences LLC, Sealife PHARMA GMBH, Shanghai Space Peptides Pharmaceutical Co Ltd, Shionogi & Co Ltd, Spero Therapeutics Inc, Synereca Pharmaceuticals, Techulon Inc, Tetraphase Pharmaceuticals Inc, Vaxdyn SL, VenatoRx Pharmaceuticals Inc, Xellia Pharmaceuticals ApS

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
46 Companies investing in Acinetobacter Infections pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Acinetobacter Infections pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included
1. ACINETOBACTER INFECTIONS PIPELINE MARKET INSIGHTS, 2020

1.1 Acinetobacter Infections Disease Overview
1.2 Acinetobacter Infections Drug Pipeline Snapshot, 2020
  1.2.1 Acinetobacter Infections Pipeline Drugs by Phase
  1.2.2 Acinetobacter Infections Pipeline Drugs by Company
  1.2.3 Acinetobacter Infections Pipeline Drugs by Mechanism of Action
  1.2.4 Acinetobacter Infections Pipeline Drugs by Route of Administration

2. ACINETOBACTER INFECTIONS COMPANY WISE PIPELINE DETAILS

ABAC Therapeutics SA Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Abgentis Ltd Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Achaogen Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Acies Bio, d.o.o. Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
AiCuris GmbH & Co KG Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
AmpliPhi Biosciences Corp Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Appili Therapeutics Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Aridis Pharmaceuticals Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
AstraZeneca Plc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Atterx Biotherapeutics Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Bioharmony Therapeutics Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
C3J Therapeutics Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Chelation Partners Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
ContraFect Corporation Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
CSA Biotechnologies LLC Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Destiny Pharma Plc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Eligochem Ltd Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
EnBiotix Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Entasis Therapeutics Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
F. Hoffmann-La Roche Ltd Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Fedora Pharmaceuticals Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Forge Therapeutics Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Fundaci?n MEDINA Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Hsiri Therapeutics LLC Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
KBP BioSciences Co Ltd Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
LegoChem Biosciences Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Meiji Seika Pharma Co Ltd Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Melinta Therapeutics Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Neoculi Pty Ltd Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Novabiotics Ltd Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Octagon Therapeutics Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Peptilogics Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Pfizer Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Pylum Biosciences Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Redx Pharma Plc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
RMH Sciences LLC Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Sealife PHARMA GMBH Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Shanghai Space Peptides Pharmaceutical Co Ltd Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Shionogi & Co Ltd Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Spero Therapeutics Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Synereca Pharmaceuticals Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Techulon Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Tetraphase Pharmaceuticals Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Vaxdyn SL Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
VenatoRx Pharmaceuticals Inc Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Xellia Pharmaceuticals ApS Acinetobacter Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. ACINETOBACTER INFECTIONS DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. ACINETOBACTER INFECTIONS PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts


More Publications